Rila Therapeutics
South San Francisco, US · Founded 2021 · Delaware corporation
Founders & leadership
RD
Robert DrakasExecutive
Board
MH
Michael HuiBoard director
WD
William DaiBoard director
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2024
▶$7MraisedJan 2025 · 3 investors · BiotechnologyRule 506(b)
▶$7MraisedJan 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert DrakasExecutive Officer, Director
- Michael HuiDirector
- William DaiDirector
- Offering amount
- $10.8M
- Amount sold
- $7M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Rila Therapeutics raised?
- Rila Therapeutics has disclosed $7M raised across 1 round.
- Where is Rila Therapeutics headquartered?
- Rila Therapeutics is headquartered in South San Francisco, US.